In the News - News
As one of the leaders of the largest employer in the state, University of Alabama at Birmingham Health System CEO Will Ferniany compares running the operation to controlling a battleship.
Three of the world's most-cited researchers work at Huntsville's HudsonAlpha Institute for Biotechnology, according to a new report on the world's most influential scientists in 2014. Other Alabama researchers are on the most-cited list. They are: Robin D. Rogers, chemistry, University of Alabama in Tuscaloosa; Casey T. Weaver, immunology, University of Alabama in Birmingham; Julie M. Decker, microbiology, UAB; Jesus F. Salazar-Gonzalez, microbiology, UAB; and J. David Sweatt, neuroscience and behavior, UAB.
UAB choir headed for World Choir Games in Latvia, but first wish them 'bon voyage' at July 3 concert
The Interkultur World Choir Games may not draw the attendance and viewer numbers of the World Cup, but they may be the equivalent competition among choral groups.
"So I don't think eating more [fruits and vegetables] alone is necessarily an effective approach for weight loss because just adding them on top of whatever foods a person may be eating is not likely to cause weight change," said Kathryn Kaiser, an instructor in the School of Public Health at the University of Alabama at Birmingham.
Birmingham and the Hoover metro area rank sixth in the nation when it comes to pedestrian fatalities. UAB Psychologist Dr. David Schwebel has developed a life sized simulator to help teach children how to safely cross the street.
David Schwebel, a University of Alabama at Birmingham psychology professor, has designed a simulator to teach children how to safely cross the street in Birmingham, one of the nation's most dangerous cities for pedestrians.
Researchers at the University of Alabama at Birmingham have shed new light on how cells called gliomas migrate in the brain and cause devastating tumors.
Researchers say it is time to abandon some popular but erroneous obesity myths. In a new article, the team presents nine obesity myths and 10 commonly held but unproven presumptions that the authors suggest lead to poor policy decisions, inaccurate public health recommendations and wasted resources.
Dipping quickly into the gift of $1 million from an anonymous donor, Alabama Institute of Medicine, has approved three grants for stem cell research totaling about that amount. The board of directors voted last week to approve the grants to three separate projects at the University of Alabama at Birmingham
The volume of information patients are given pre-operatively often exceeds their short-term memories, says lead author Thomas Vetter, MD, MPH, of the Department of Anesthesiology at the University of Alabama at Birmingham School of Medicine. "Our findings show that providing patients with a standardized instruction sheet … with simple language can improve compliance significantly."
A novel inhibitor of CD19 was well tolerated and showed promising activity in patients with relapsed or refractory B-lineage non-Hodgkin lymphoma (NHL), according to a phase I study.
According to a study by the University of Alabama at Birmingham, researchers found that gliomas disturb normal neural connections and seize control of blood vessels. In order to move away from the central tumor, gliomas travel along blood vessels, which give them access to the blood supply for nutrients.
Facebook and UAB consult with each other on what to research and even what to teach. And this is typical nowadays when corporations team up with colleges. Relationships are cozier and more targeted.
The Edge of Chaos announced last week that it is creating a new Scholars Program to bring together some of the finest minds at UAB to attack what the venue's web site calls the "wicked problems" that "plague communities" and are difficult to solve.
In the article titled "Birmingham's Health IT Breeding Ground," Ken Congdon wrote about his recent visit to Birmingham where he learned of UAB's and Innovation Depot's role in helping grow the health IT industry here.
From Diabetes In Control.com
"We made a lot of assumptions and jumped to a lot of conclusions that the markers of cardiovascular disease and treatments for prevention of cardiovascular diseases will be the same in type 1 — and that just may not be the case," said Fernando Ovalle, MD, director of the Comprehensive Diabetes Center of the University of Alabama at Birmingham. "This could potentially change the perspective on how we see the use of statins and the assessment of cardiovascular risk in general."
"We made a lot of assumptions and jumped to a lot of conclusions that the markers of cardiovascular disease and treatments for prevention of cardiovascular diseases will be the same in type 1 — and that just may not be the case," said Fernando Ovalle, MD, director of the Comprehensive Diabetes Center of the University of Alabama at Birmingham. "This could potentially change the perspective on how we see the use of statins and the assessment of cardiovascular risk in general."
From WIAT.com
Dr. John Sloan, a Criminal Justice Professor at the University of Alabama at Birmingham says prosecutors carry a heavy burden. Once police wrap up their reports and interviews, it is up to them to decide whether or not a child being left in a vehicle is a gross deviation from the expected standard of care or a tragic accident.
Dr. John Sloan, a Criminal Justice Professor at the University of Alabama at Birmingham says prosecutors carry a heavy burden. Once police wrap up their reports and interviews, it is up to them to decide whether or not a child being left in a vehicle is a gross deviation from the expected standard of care or a tragic accident.
“Individuals with HCV are large users of outpatient, ED and inpatient services with increased and rising utilization by persons born between 1945 and 1965,” James Galbraith, MD, associate professor of emergency medicine at the University of Alabama at Birmingham, told Infectious Disease News. “This not only presents a large economic burden on the health system, but more importantly highlights opportunities to identify these individuals and refer them to potentially curative treatment.”
"It's not very often that a new therapy comes along that has as much potential as this new, leadless pacemaker does," said Vance Plumb, M.D., professor of medicine in the Division of Cardiovascular Disease in the School of Medicine. "Historically, the weak link causing failure of pacing has been the leads, which this device eliminates. It's a big step forward in patient treatment and a milestone for cardiac rhythm treatment in Alabama."
Louis Brunsting, M.D, associate professor of surgery and chief of the Section of Minimally Invasive Cardiac Surgery at the University of Alabama at Birmingham and Massoud Leesar, M.D., professor of medicine and chief of the Section of Interventional Cardiology, modified the procedure to take place over three days instead of all at one time to decrease the risk of bleeding a patient could endure due to blood-thinning medication taken prior to the stenting procedure.
Approved by University of Alabama System Board of Trustees last week, UAB is creating the Personalized Medicine Institute, the Institute for Informatics and the UAB-HudsonAlpha Center for Genomic Medicine.